
The INTEGRA study assessed a tailored multicomponent health care intervention's impact on glycaemic control in poorly managed type 2 diabetes. Intervention recipients achieved significantly greater reduction in glycated haemoglobin (HbA1c) levels than those under standard care, with sustained benefits. This approach, focusing on therapeutic intensification, offers promise for enhanced glycaemic management.
Like
Save
Share